Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203229 · ClinicalTrials.gov registry record · NA
Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia
A NA study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00203229 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 20 participants.
The verdict
NCT00203229, a NA study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This research study will look at the safety (e.g., the occurrence of side effects) and efficacy (how well the drug works in reducing trigeminal neuralgia attacks) of a drug called lamotrigine in adults with trigeminal neuralgia.
Interventions
- DRUG Placebo
- DRUG lamotrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-06 |
| Est. Completion | 2006-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00203229
The ClinicalTrials.gov registry entry for NCT00203229 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00203229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00203229 about?
NCT00203229 is a clinical study titled "Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia". This research study will look at the safety (e.g., the occurrence of side effects) and efficacy (how well the drug works in reducing trigeminal neuralgia attacks) of a drug called lamotrigine in adults with trigeminal neuralgia.
What is the current status of trial NCT00203229?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2003-06. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00203229?
The interventions under investigation include: Placebo (DRUG), lamotrigine (DRUG).
Who is sponsoring clinical trial NCT00203229?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.